Cargando…
GaPP: a pilot randomised controlled trial of the efficacy of action of gabapentin for the management of chronic pelvic pain in women: study protocol
INTRODUCTION: Chronic pelvic pain (CPP) affects >1 million UK women. Annual healthcare costs are estimated at >£150 million. Proven interventions for CPP are limited, and treatment is often unsatisfactory. Gabapentin is increasingly prescribed due to reports of effectiveness in other chronic p...
Autores principales: | Horne, Andrew W, Critchley, Hilary O D, Doust, Ann, Fehr, Daniel, Wilson, John, Wu, Olivia, Jack, S, Porter, Maureen, Lewis, Steff, Bhattacharya, Siladitya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371581/ https://www.ncbi.nlm.nih.gov/pubmed/22685224 http://dx.doi.org/10.1136/bmjopen-2012-001297 |
Ejemplares similares
-
GaPP2, a multicentre randomised controlled trial of the efficacy of gabapentin for the management of chronic pelvic pain in women: study protocol
por: Vincent, Katy, et al.
Publicado: (2018) -
Gabapentin for the Management of Chronic Pelvic Pain in Women (GaPP1): A Pilot Randomised Controlled Trial
por: Lewis, Steff C., et al.
Publicado: (2016) -
Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, double-blind, placebo-controlled trial
por: Horne, Andrew W, et al.
Publicado: (2020) -
Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of a combination of gefitinib and methotrexate to treat tubal ectopic pregnancies (GEM II): study protocol
por: Horne, Andrew W, et al.
Publicado: (2013) -
The use of brain functional magnetic resonance imaging to determine the mechanism of action of gabapentin in managing chronic pelvic pain in women: a pilot study
por: Seretny, Marta, et al.
Publicado: (2019)